| Followers | 829 |
| Posts | 119681 |
| Boards Moderated | 16 |
| Alias Born | 09/05/2002 |
Friday, March 16, 2007 5:15:28 AM
Subtle Changes in the Pipeline Description
On the left is the pipeline chart from Nov 2006;
on the right is the pipeline chart from the Cowen
webcast this week. See below for differences.
What has changed? Four things:
1. In the latest chart, the FVIIa program has an extra line showing development for ICH/trauma in addition to the main indication of hemophilia. (I find the mention of ICH surprising given the recent failure of NovoSeven in ICH: #msg-17380185.)
2. In the latest chart, the rhAAT program has an extra line showing development for respiratory diseases (e.g. COPD) in addition to the main indication for hereditary deficiency (HD).
3. In the latest chart, the CD137 program is described as being for tumors and autoimmune rather than just tumors.
4. The malaria program is no longer shown. This may reflect diminished confidence in GTC’s ability to secure sufficient government funding to proceed.
On the left is the pipeline chart from Nov 2006;
on the right is the pipeline chart from the Cowen
webcast this week. See below for differences.
What has changed? Four things:
1. In the latest chart, the FVIIa program has an extra line showing development for ICH/trauma in addition to the main indication of hemophilia. (I find the mention of ICH surprising given the recent failure of NovoSeven in ICH: #msg-17380185.)
2. In the latest chart, the rhAAT program has an extra line showing development for respiratory diseases (e.g. COPD) in addition to the main indication for hereditary deficiency (HD).
3. In the latest chart, the CD137 program is described as being for tumors and autoimmune rather than just tumors.
4. The malaria program is no longer shown. This may reflect diminished confidence in GTC’s ability to secure sufficient government funding to proceed.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
